CIK 0001357459
- Non-accelerated filer
- Smaller reporting company
PALISADE BIO, INC.
Sign in to watch- Ticker
- PALI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 522007292
- Phone
- +1 858-704-4900
- Business address
- 7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
- Former names
- PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
- Open-market buys, last 90 days
- $28,800
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$28,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-09-02 | JOHE KARL Chief Scientific Officer | Sale | −6,000 | $4.09 | $25K | 495,747 |
| 2014-08-07 | GARR RICHARD CEO | Gift | −68,500 | 1,168,837 | ||
| 2014-08-07 | GARR RICHARD CEO | Gift | −68,500 | 1,100,337 | ||
| 2014-08-01 | OLDAKER WILLIAM CLYDE Director | Grant or award · Common Stock purchase option | +72,884 | 72,884 | ||
| 2014-04-03 | JOHE KARL Chief Scientific Officer | Gift | +17,500 | 495,747 | ||
| 2013-04-01 | WESTREICH STANLEY Director | Grant or award · Common Stock purchase option | +57,440 | 57,440 | ||
| 2013-04-01 | OLDAKER WILLIAM CLYDE Director | Grant or award · Common Stock purchase option | +57,440 | 57,440 | ||
| 2007-03-13 | REGAL ONE CORP 10% owner | Other disposition | −97 | 1,293,814 | ||
| 2007-02-05 | REGAL ONE CORP 10% owner | Other disposition | −500,376 | 1,293,911 |
Page 21 of 21 · 409 trades